News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,235 Results
Type
Article (49329)
Company Profile (314)
Press Release (677592)
Section
Business (212094)
Career Advice (2090)
Deals (36505)
Drug Delivery (98)
Drug Development (83461)
Employer Resources (169)
FDA (16914)
Job Trends (15677)
News (358844)
Policy (34615)
Tag
Academia (2758)
Alliances (51431)
Alzheimer's disease (1340)
Approvals (16874)
Artificial intelligence (176)
Bankruptcy (366)
Best Places to Work (12060)
Biotechnology (216)
Breast cancer (212)
Cancer (1557)
Cardiovascular disease (127)
Career advice (1751)
Cell therapy (313)
Clinical research (66819)
Collaboration (580)
Compensation (308)
COVID-19 (2675)
C-suite (139)
Data (1484)
Diabetes (192)
Diagnostics (6406)
Earnings (87143)
Employer resources (147)
Events (115310)
Executive appointments (484)
FDA (17707)
Funding (523)
Gene therapy (218)
GLP-1 (668)
Government (4608)
Healthcare (19823)
Infectious disease (2775)
Inflammatory bowel disease (119)
Interviews (317)
IPO (16754)
Job creations (4040)
Job search strategy (1497)
Layoffs (442)
Legal (8423)
Lung cancer (230)
Manufacturing (220)
Medical device (14230)
Medtech (14235)
Mergers & acquisitions (20006)
Metabolic disorders (521)
Neuroscience (1716)
NextGen: Class of 2025 (6905)
Non-profit (4731)
Northern California (1874)
Obesity (301)
Opinion (199)
Parkinson's disease (109)
Patents (134)
People (59466)
Phase I (20774)
Phase II (29360)
Phase III (21940)
Pipeline (614)
Postmarket research (2739)
Preclinical (8840)
Radiopharmaceuticals (249)
Rare diseases (290)
Real estate (6290)
Regulatory (23193)
Research institute (2474)
Resumes & cover letters (359)
Southern California (1623)
Startups (3820)
United States (16931)
Vaccines (614)
Weight loss (220)
Date
Today (26)
Last 7 days (473)
Last 30 days (1880)
Last 365 days (35708)
2025 (1626)
2024 (36144)
2023 (41147)
2022 (52382)
2021 (57101)
2020 (55915)
2019 (48798)
2018 (36939)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (789)
Arizona (211)
Asia (40539)
Australia (6675)
California (4265)
Canada (1557)
China (367)
Colorado (197)
Connecticut (216)
Europe (87651)
Florida (601)
Georgia (154)
Illinois (446)
Indiana (245)
Maryland (710)
Massachusetts (3333)
Michigan (187)
Minnesota (325)
New Jersey (1199)
New York (1213)
North Carolina (838)
Northern California (1874)
Ohio (153)
Pennsylvania (1000)
South America (1182)
Southern California (1623)
Texas (623)
Utah (122)
Washington State (440)
727,235 Results for "corvia medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards
December 23, 2024
·
2 min read
News
Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients
October 25, 2024
·
3 min read
Genetown
Newly Published Data in JAMA Cardiology Demonstrates Favorable Long-term Effects of the Corvia Atrial Shunt in Heart Failure Patients
Corvia Medical, Inc announced the publication in JAMA Cardiology of two-year echocardiographic data from its REDUCE LAP-HF II randomized clinical trial of the Corvia® Atrial Shunt, offering groundbreaking insight into the impact of a shunt on the heart.
May 7, 2024
·
2 min read
Drug Development
Corvia Medical Releases Two-year Clinical Trial Results Confirming Sustained Benefit and Safety of Its Atrial Shunt in Heart Failure Patients
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, announced two-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt in properly selected heart failure patients with preserved or mildly reduced ejection fraction.
May 22, 2023
·
3 min read
Genetown
CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL
Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), announced the first patient has been randomized in RESPONDER-HF, a global confirmatory trial of the Corvia Atrial Shunt in heart failure patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction.
December 6, 2022
·
4 min read
Press Releases
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular
January 13, 2025
·
2 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
January 8, 2025
·
7 min read
Press Releases
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
January 15, 2025
·
1 min read
Press Releases
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
January 17, 2025
·
6 min read
Press Releases
CardioSight, Inc appoints Niv Ad, M.D. as Chief Medical Officer
December 30, 2024
·
3 min read
1 of 72,724
Next
